• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Onc IC plan

Anonymous

Guest
Good news it looks we are going back to a sales based IC plan. Imagine that, thanks OB for the sorry current plan.

I hope DC and the RDs read this thread though.

A MAJOR concern is how will this new plan be based? If it is NRx, PLEASE look at the current configuration on territories. In my district for example, there are HUGE discrepancies in territory sizes amongst the reps. There are a couple large territories and a couple that are more than half those when looking at aloxi and Halaven data and goals. This should be adjusted for any new plan. Thank you.